• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

临床输血与检验 ›› 2026, Vol. 28 ›› Issue (5): 748-755.DOI: 10.3969/j.issn.1671-2587.2026.05.012

• 临床输血 • 上一篇    下一篇

成人噬血细胞综合征输血特征及预后的相关性分析

钟明璐, 成小红, 苑召虎, 黄建云, 魏亚明   

  1. 广州市第一人民医院,广东广州 510000
  • 收稿日期:2026-09-05 修回日期:2026-09-22 出版日期:2026-10-20 发布日期:2026-11-11
  • 通讯作者: 魏亚明,主要从事输血医学方面研究,(E-mail)weiyaming@163.com。
  • 作者简介:钟明璐,主要从事输血治疗方面研究,(E-mail)drzhongml@163.com。

Correlation Analysis between Blood Transfusion Characteristics and Prognosis in Adult Hemophagocytic Lymphohistiocytosis

ZHONG Minglu, CHENG Xiaohong, YUAN Zhaohu, HUANG Jianyun, WEI Yaming   

  1. Guangzhou First People's Hospital, Guangzhou, Guangdong 510000
  • Received:2026-09-05 Revised:2026-09-22 Online:2026-10-20 Published:2026-11-11

摘要: 目的 初步探索成人噬血细胞综合征(HLH)患者的输血特征、输血量、输血疗效和预后的关联。方法 本研究回顾性纳入2018年1月—2024年12月广州市第一人民医院50例成人HLH患者,均符合HLH-2004诊断标准,收集患者人口学资料、实验室指标、各类血制品输注记录及随访生存数据,对比存活与非存活患者血液制品使用差异,分析输血量与血小板输注疗效、炎症标志物及生存结局的相关性。结果 50例患者中共输注血小板439 U、悬浮红细胞572 U,60%患者合并凝血功能障碍;非存活组血小板、血浆、日均红细胞及血小板输注量均显著高于存活组(P均<0.05);血小板抗体筛查阳性率28%,抗体阳性率与血小板输注量呈正相关,校正血小板回收率与输注总量呈负相关。随着红细胞输注阈值升高,Hb校正增量下降,PLT<10×109/L输注阈值的输注后24 h血小板回收率(platelet post-transfusion recovery, PPR)最低;高红细胞输注量(≥8 U)和输血后铁蛋白、高血小板输注量(≥7 U)和输注后白细胞介素-10呈现同步上升趋势;多因素分析中凝血功能障碍是不良预后相关因素。结论 HLH患者输血需求量高,输血量增多并不能带来更大生存获益。凝血功能障碍是HLH预后不良的危险因素。

关键词: 噬血细胞综合征, 输血策略, 预后, 血小板回收率, 铁蛋白, 细胞因子

Abstract: Objective To explore the association between the transfusion characteristics, transfusion volume, transfusion efficacy and prognosis of adult patients with hemophagocytic lymphohistiocytosis (HLH). Methods This study retrospectively enrolled 50 adult patients with HLH in the First People's Hospital of Guangzhou from January 2018 to December 2024. All patients met the diagnostic criteria of HLH-2004. Demographic data, laboratory indicators, infusion records of various blood products, and follow-up survival data of the patients were collected. We compared the differences in the use of blood products between survivors and non-survivors, and analyze the correlation between blood transfusion volume and the therapeutic effect of platelet transfusion, inflammatory markers, and survival outcomes. Results Among the 50 patients, a total of 439 U of platelets and 572 U of suspended red blood cell (RBC) were infused. 60% of the patients had coagulation dysfunction. The non-survivor group had significantly higher transfusion volumes of platelets, plasma, as well as daily mean RBC and platelet transfusions compared to the survivor group (all P<0.05). The positive rate of platelet antibody screening was 28%, which was positively correlated with the platelet transfusion volume, while the adjusted platelet recovery rate was negatively correlated with the total transfusion volume. With the increase of the RBCs transfusion threshold, the corrected hemoglobin increment decreased, and the 24-hour platelet post-transfusion recovery (PPR) is the lowest when the PLT<10×109/L transfusion threshold. High RBC transfusion volume (≥8 U) was associated with a synchronous increase in post-transfusion ferritin after blood transfusion, and high platelet transfusion volume (≥7 U) was associated with a synchronous increase in post-transfusion interleukin-10. Multivariate analysis identified coagulation dysfunction as a factor related to poor prognosis. Conclusion Patients with HLH have a high demand for blood transfusion. An increase in blood transfusion volume does not bring greater survival benefits. Coagulation dysfunction is a risk factor for poor prognosis of HLH.

Key words: Hemophagocytic lymphohistiocytosis, Blood transfusion strategy, Prognosis, Platelet post-transfusion recovery, Ferritin, Cytokine

中图分类号: